𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Overexpression of CC3/TIP30 is associated with HER-2/neustatus in breast cancer

✍ Scribed by Dao-Hai Zhang; Lee Lee Wong; Lee Kian Tai; Evelyn SC Koay; Robert E Hewitt

Book ID
106123537
Publisher
Springer-Verlag
Year
2005
Tongue
English
Weight
374 KB
Volume
131
Category
Article
ISSN
1432-1335

No coin nor oath required. For personal study only.

πŸ“œ SIMILAR VOLUMES

Folate receptor overexpression is associ
Folate receptor overexpression is associated with poor outcome in breast cancer
✍ Lynn C. Hartmann; Gary L. Keeney; Wilma L. Lingle; Teresa J.H. Christianson; Bin πŸ“‚ Article πŸ“… 2007 πŸ› John Wiley and Sons 🌐 French βš– 300 KB πŸ‘ 1 views

## Abstract The high affinity folate receptor is a membrane‐associated glycoprotein that is preferentially expressed in cancers of epithelial origin and rarely expressed in normal cells. We examined its expression pattern in breast cancer, utilizing a tissue microarray containing samples from 63 in

Nup88 mRNA overexpression is associated
Nup88 mRNA overexpression is associated with high aggressiveness of breast cancer
✍ David Agudo; Francisco GΓ³mez-Esquer; Fernando MartΓ­nez-Arribas; MariΓ‘ JosΓ© NΓΊΓ±ez πŸ“‚ Article πŸ“… 2004 πŸ› John Wiley and Sons 🌐 French βš– 99 KB πŸ‘ 1 views

## Abstract The nuclear pore complex protein Nup88 is overexpressed in tumor cells. Immunohistochemical studies have shown that this overexpression is linked to higher aggressiveness of colorectal carcinoma and to enhanced metastatic potential of melanoma cells. However, the antibodies so far devel

Overexpression of Id-1 is associated wit
Overexpression of Id-1 is associated with poor clinical outcome in node negative breast cancer
✍ Sebastian F. Schoppmann; Monika Schindl; Guenther Bayer; Klaus Aumayr; Julia Die πŸ“‚ Article πŸ“… 2003 πŸ› John Wiley and Sons 🌐 French βš– 427 KB πŸ‘ 1 views

## Abstract Id‐1 is an important regulator of cellular growth and differentiation and controls malignant progression of breast cancer cells. The aim of our study was to assess the clinical impact of Id‐1 expression in breast cancer, __i.e.__, its potential impact on prognosis and prediction of trea